Skip to content
Subscribe
Billionaire Profile
Satish Mehta
Global Rank
#1973

Image: Ministry of Culture | GODL-India | via Wikimedia Commons

Satish Mehta

CEO, Pharmaceuticals
Pune, Maharashtra
Real-Time Net Worth
$2.12B
Estimated based on Pharmaceuticals stock value as of September 10, 2026
-0.46% (24h)
Age
75
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
India

Biography

Satish Mehta is a prominent figure in the pharmaceutical industry and a successful entrepreneur. He is the founder of Emcure Pharmaceuticals, one of India's leading pharmaceutical companies, and has built a diverse portfolio of investments. His career spans over four decades, during which he has overseen Emcure's growth into a global enterprise with operations in over 70 countries. Mehta's net worth reflects his successful ventures in pharmaceuticals and his ability to build and expand the company. He is recognized for his commitment to making healthcare accessible and affordable.

AI-Assisted Draft
Not yet reviewed by an editor — how we work
Data Updated
Sep 10, 2026
Report a Correction

Wealth Over Time

Net Worth History

YearNet Worth
2026$2.12B
2025$1.70B
2024$1.70B

Portfolio Holdings

Emcure Pharmaceuticals

Emcure Pharmaceuticals

healthcare
Pune, Maharashtra, India
11,000+ employees
Founded 1981

In-Depth Profile

Early Life and Education

Satish Mehta's journey began with a vision to revolutionize healthcare in India. After graduating from IIM Ahmedabad, he decided to embark on an entrepreneurial path, setting the stage for Emcure Pharmaceuticals. His father was a pharma retailer, which gave him early insights into the industry.

Rise to Success

Founded in 1981 with a loan of ₹3 lakh, Emcure Pharmaceuticals rapidly grew under Satish Mehta's leadership. The company initially focused on contract manufacturing and gradually expanded into branded generics. Under his leadership, Emcure became a leading pharmaceutical company in India and then expanded globally.

Key Business Strategies

Mehta's leadership emphasized innovation and strategic acquisitions. Emcure invested significantly in research and development and expanded its product portfolio through both organic growth and strategic acquisitions. This approach helped the company enter global markets, particularly the US. Furthermore, Emcure went public in July 2024, listed at a premium, to further its expansion.

Philanthropy

Satish Mehta believes in giving back to society. Emcure sponsors life-saving surgeries, supports education for underprivileged students, and has adopted villages to promote environmental sustainability. His PRERNA initiative empowers women employees, and the NEEM scheme boosts skill development, reinforcing Emcure's commitment to community. Also, Mehta has been recognized with the 'India for Humanity' initiative.

Career Milestones

1981

Founded Emcure Pharmaceuticals

Started Emcure as a contract manufacturer for multinationals.

1994

Sun Pharma listed on the stock exchange

Sun Pharma was listed on the stock exchange with an oversubscribed issue.

2005-2006

Entered regulated markets

Emcure started building operations in various countries.

2024

Emcure Pharmaceuticals listed on the stock exchange

Emcure was listed at a 31% premium.

Philanthropy & Social Impact

Healthcare

Sponsorship of life-saving surgeries

Undisclosed

Emcure supports medical initiatives.

Education

Education for underprivileged students

Undisclosed

Supports educational programs.

Environmental

Village adoption and environmental sustainability

Undisclosed

Promoting awareness about environmental sustainability.

Social Empowerment

PRERNA initiative

Undisclosed

Empowers women employees

Skill Development

NEEM scheme

Undisclosed

Boosts skill development.

Business Philosophy & Leadership

Notable Quotes

"Money is a part of it. But the need to achieve higher goals is what propels me."

Leadership Principles

Focus on Innovation

Investing in R&D to develop cutting-edge molecules and differentiated products.

Socially Committed Enterprise

Emphasizing philanthropy and community development.

Strategic Global Expansion

Prioritizing a strong base in India before expanding into international markets.

Controversies & Challenges

2017

Price Fixing Scandal

Related to Heritage Pharmaceuticals, a US subsidiary of Emcure.

Billionaires Connected to Satish Mehta

Peers in Healthcare

All Healthcare billionaires →

Richest in India

All billionaires from India →

Adjacent Global Ranks

Full global ranking →

Compare Satish Mehta

Net Worth Face-off
Satish Mehta vs Elon Musk
Compare Wealth →
Net Worth Face-off
Satish Mehta vs Jeff Bezos
Compare Wealth →
Net Worth Face-off
Satish Mehta vs Mark Zuckerberg
Compare Wealth →

Frequently Asked Questions

What is Satish Mehta's net worth in 2026?
As of 2026, Satish Mehta's estimated net worth is $2.117 billion, ranking #1973 among the world's billionaires. The estimate is based on publicly available shareholding data and market prices, updated daily.
How did Satish Mehta make their money?
Satish Mehta's wealth primarily comes from Pharmaceuticals, most notably through Pharmaceuticals.
Where is Satish Mehta from?
Satish Mehta is from India.
How old is Satish Mehta?
Satish Mehta is 75 years old.

Sources & References

  1. Satish Mehta — Forbes profile — Forbes